Imaging Technique Highlights Early Signs of Emphysema
WASHINGTON, DC -- April 5, 2010 -- Measuring differences inblood flow patterns in the lungs may help researchers identify which smokers are most likely to develop emphysema and could provide earlier warnings to those at risk of the disease. The findings are available in the latest issue of Proceedings of the National Academy of Sciences (PNAS).
NEWS
VIDA DIAGNOSTICS FOUNDER GEOFFREY MCLENNAN, 62
In memory of Dr. Geoffrey McLennan for his contribution and dedication to VIDA Diagnostics and furthering the field of pulmonary quantitative imaging. He will be greatly missed by his colleagues and family.
Professor Geoffrey McLennan MBBS, FRACP, PhD age 62, of Iowa City, died of metastatic osteogenic sarcoma on Tuesday, July 27th at the University of Iowa Hospitals. He was surrounded by his family's love.
Funeral services will be held at 3 pm Friday, July 30th, 2010, at First Presbyterian Church in Iowa City. Memorials may be made to the Geoffrey McLennan Faculty Fellowship Fund at the University of Iowa Foundation: UI Foundation, PO Box 4550, Iowa City, IA 52244-4550. Online condolences may be sent to Geoffrey's family at www.gayandciha.com.
VIDA is dedicated to providing the most clinically validated solution for the quantitative assessment of pulmonary disease.
Validated in over 25,000 exams in comprehensive clinical trials, VIDA is the most comprehensively tested solution available today.
Read more on PW2>>
VIDA Diagnostics is a leader in quantitative pulmonary image analysis for the diagnosis and treatment of pulmonary diseases.
The FDA-cleared Pulmonary Workstation 2.0 (PW2) is the leading lung analysis tool for COPD, emphysema and asthma. Participating in the emerging pulmonary device market that is expected to grow to nearly $3.8 billion by 2011, VIDA’s vision is to establish lung quantitative CT methods as the standard of care for diagnosis and staging of chronic lung disease.
Founded by four University of Iowa faculty members, Eric Hoffman, Ph.D., Geoffrey McLennan, M.D., Ph.D., Joseph Reinhardt, Ph.D and, Milan Sonka, Ph.D., VIDA Diagnostics is based on research associated with the UI’s Iowa Comprehensive Lung Imaging Center directed by Dr. Hoffman and on core technology licensed from the UI Research Foundation.
